| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.4 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.045 | 0.4 |